THIOREDOXIN AND THIOREDOXIN REDUCTASE IN THE PATHOGENESIS OF SELECTED HUMAN DISEASES, PART II

被引:0
作者
Popielarski, Marcin [1 ]
Ponamarczuk, Halszka [1 ]
Kusinska, Katarzyna [1 ]
Swiatkowska, Maria [1 ]
机构
[1] Uniwersytet Med & Lodzi, Zaklad Cytobiol & Prote, Katedra Nauk Biomed, Ul Mazowiecka 6-8, PL-92215 Lodz, Poland
关键词
thioredoxin; thioredoxin reductase; cancers; oxidative stress; apoptosis; CANCER-CELL-GROWTH; 1-METHYLPROPYL 2-IMIDAZOLYL DISULFIDE; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MITOCHONDRIAL COMPLEX-III; MAMMALIAN THIOREDOXIN; ARSENIC TRIOXIDE; ORGANOTELLURIUM COMPOUNDS; MOTEXAFIN GADOLINIUM; MOLECULAR-MECHANISMS; GOLD(I) COMPLEXES;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Thioredoxin and thioredoxin reductase form a thioredoxin system, which is involved in protecting cells against oxidative stress, regulation of apoptosis and regulation of tumorigenesis. Defects in thioredoxin system are associated with the pathogenesis of many human diseases, including the development of cancer. Overexpression of thioredoxin and thioredoxin reductase leads to increased proliferation, angiogenesis and initiation of anti-apoptotic pathways. Increased levels of thioredoxin and thioredoxin reductase are considered to be one of the mechanisms correlated with drug resistance in malignant cells. We can observe growing evidences suggesting the role of thioredoxin and thioredoxin reductase inhibitors in treatment of tumors. Results of therapy using thioredoxin and thioredoxin reductase inhibitors seems to be very promising.
引用
收藏
页码:159 / 179
页数:21
相关论文
共 50 条
  • [41] Studies toward Novel Peptidomimetic Inhibitors of Thioredoxin-Thioredoxin Reductase System
    Klossowski, Szymon
    Muchowicz, Angelika
    Firczuk, Malgorzata
    Swiech, Marta
    Redzej, Adam
    Golab, Jakub
    Ostaszewski, Ryszard
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (01) : 55 - 67
  • [42] Activity assays of mammalian thioredoxin and thioredoxin reductase: Fluorescent disulfide substrates, mechanisms, and use with tissue samples
    Montano, Sergio J.
    Lu, Jun
    Gustafsson, Tomas N.
    Holmgren, Arne
    ANALYTICAL BIOCHEMISTRY, 2014, 449 : 139 - 146
  • [43] Expression and purification of thioredoxin (TrxA) and thioredoxin reductase (TrxB) from Brevibacillus choshinensis
    Tanaka, R
    Kosugi, K
    Mizukami, M
    Ishibashi, M
    Tokunaga, H
    Tokunaga, M
    PROTEIN EXPRESSION AND PURIFICATION, 2004, 37 (02) : 385 - 391
  • [44] Mercury and selenium interaction in vivo: Effects on thioredoxin reductase and glutathione peroxidase
    Branco, Vasco
    Canario, Joao
    Lu, Jun
    Holmgren, Arne
    Carvalho, Cristina
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 52 (04) : 781 - 793
  • [45] Oxidation of structural cysteine residues in thioredoxin 1 by aromatic arsenicals enhances cancer cell cytotoxicity caused by the inhibition of thioredoxin reductase 1
    Zhang, Xu
    Lu, Jun
    Ren, Xiaoyuan
    Du, Yatao
    Zheng, Yujuan
    Ioannou, Panayiotis V.
    Holmgren, Arne
    FREE RADICAL BIOLOGY AND MEDICINE, 2015, 89 : 192 - 200
  • [46] Inhibition of thioredoxin reductase by lanthanum chloride
    Citta, Anna
    Folda, Alessandra
    Scutari, Guido
    Cesaro, Luca
    Bindoli, Alberto
    Rigobello, Maria Pia
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2012, 117 : 18 - 24
  • [47] Exposure to Silver Nanoparticles Inhibits Selenoprotein Synthesis and the Activity of Thioredoxin Reductase
    Srivastava, Milan
    Singh, Sanjay
    Self, William T.
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2012, 120 (01) : 56 - 61
  • [48] B5, a thioredoxin reductase inhibitor, induces apoptosis in human cervical cancer cells by suppressing the thioredoxin system, disrupting mitochondrion-dependent pathways and triggering autophagy
    Shao, Fang-Yuan
    Du, Zhi-Yun
    Ma, Dong-Lei
    Chen, Wen-Bo
    Fu, Wu-Yu
    Ruan, Bi-Bo
    Rui, Wen
    Zhang, Jia-Xuan
    Wang, Sheng
    Wong, Nai Sum
    Xiao, Hao
    Li, Man-Mei
    Liu, Xiao
    Liu, Qiu-Ying
    Zhou, Xiao-dong
    Yan, Hai-Zhao
    Wang, Yi-Fei
    Chen, Chang-Yan
    Liu, Zhong
    Chen, Hong-Yuan
    ONCOTARGET, 2015, 6 (31) : 30939 - 30956
  • [49] Thioredoxin Reductase Inhibition for Cancer Therapy
    Gencheva, Radosveta
    Arner, Elias S. J.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2022, 62 : 177 - 196
  • [50] Thioredoxin in human and experimental sepsis
    Hofer, Stefan
    Rosenhagen, Claudia
    Nakamura, Hajime
    Yodoi, Junji
    Bopp, Christian
    Zimmermann, Johannes B.
    Goebel, Meike
    Schemmer, Peter
    Hoffmann, Kartrin
    Schulze-Osthoff, Klaus
    Breitkreutz, Raoul
    Weigand, Markus A.
    CRITICAL CARE MEDICINE, 2009, 37 (07) : 2155 - 2159